Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

INDOCYANINE GREEN for SELECTIVE SENTINELLA AXILLARY LYMPH NODE BIOPSY in PATIENTS with BREAST CANCER

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.

In the operating room 1 ml of indocyaninge grenn will be injectec periareolar . After 5 minutes the lymph node will be detected and extracted. The comparison between the lymph nodes detected with Technetium 99 and indocyanine green will be analysed.

Inclusion Criteria:

• Patients >18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
• N0 patients or patients who have undergone target axillary detection with good response

Exclusion Criteria:

• Lymphadenectomy